CHINA Sinovac vaccine to expand annual production capacity


Sinovac vaccine to expand annual production capacity


20:39, April 02, 2021

File photo: Xinhua

BEIJING, April 2 (Xinhua) -- The third production line of CoronaVac, an inactivated COVID-19 vaccine developed by Sinovac Biotech, was completed and put into production on Thursday. It will likely expand the company's annual production capacity to 2 billion doses.

As of Thursday, more than 200 million doses of CoronaVac, including the semi-finished ones, have been delivered to about 27 countries and regions, including China. More than 100 million doses have been administered around the globe, the company said on Friday.

So far, the Sinovac vaccine has received emergency use approval or conditional marketing authorization from more than 30 countries, the company said.

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue